Mark Lackner, Chief Officer of Zentalis Pharmaceuticals ZNTL, has filed 0 purchases and 3 sales on the open market. The latest trade was on 25/02/03.

ML

ML

Mark Lackner

Chief Scientific Officer

Company

Zentalis Pharmaceuticals ZNTL

First filing

24/02/05

Trades

9 trades

Buys / sales

0 / 3

12-month net buying

No record

Last trade

25/02/03

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Zentalis PharmaceuticalsZNTL	Open-market sale	25/02/03	25/02/05	14,368 sh	$1.71	$24,569.28	−2.7%
Zentalis PharmaceuticalsZNTL	Open-market sale	25/01/02	25/01/03	4,411 sh	$3.12	$13,762.32	−2.3%
Zentalis PharmaceuticalsZNTL	Open-market sale	24/02/02	24/02/05	1,585 sh	$11.54	$18,290.9	−0.8%